SCO-240
Growth hormone deficiency, Infertility, Alopecia
Phase 1Active
Key Facts
Indication
Growth hormone deficiency, Infertility, Alopecia
Phase
Phase 1
Status
Active
Company
About SCOHIA PHARMA
A Japanese bioventure developing innovative small molecule drugs for metabolic, cardiovascular, and renal diseases through a diversified pipeline and strategic collaborations.
View full company profile